Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Leukemia

• Publication date

  2006-05-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.leu.2404224PMID 16710305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overproduction of BCR‐ABL induces apoptosis in imatinib mesylate‐resistant cell lines

  2005cited by this paper
• Punish the parent not the progeny.

  2005cited by this paper
• Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

  2004cited by this paper
• Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo.

  2002cited by this paper
• Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells.

  2002cited by this paper
• Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL–transformed hematopoietic cell lines

  2000cited by this paper
• Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines.

  2000cited by this paper
• The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability

  2000cited by this paper
• The role of hypoxia in the maintenance of hematopoietic stem cells.

  1993cited by this paper

• Lactate‐mediated activation of GPR81 regulates BCR/Abl protein expression in chronic myeloid leukemia cells selected under low oxygen tension

  2025cites this paper
• Zinc as a potential regulator of the BCR-ABL oncogene in chronic myelocytic leukemia cells.

  2024cites this paper
• The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities

  2023cites this paper
• Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells

  2023cites this paper
• mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells

  2023influential citation
• Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies

  2022cites this paper
• Lactate Maintains BCR/Abl Expression and Signaling in Chronic Myeloid Leukemia Cells Under Nutrient Restriction

  2022cites this paper
• Leukemic Stem Cell: A Mini-Review on Clinical Perspectives

  2022cites this paper
• Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia

  2022cites this paper
• Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential

  2021cites this paper
• Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia

  2021cites this paper
• The regulation of bcr-abl in hypoxia is through the mTOR pathway

  2020cites this paper
• In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features

  2020cites this paper
• Insights into new mechanisms and models of cancer stem cell multidrug resistance.

  2020cites this paper
• Unravelling the Role of Stem Cells in Chronic Myeloid Leukaemia and Potential Treatments

  2020cites this paper
• Bone marrow microenvironment: The guardian of leukemia stem cells

  2019cites this paper
• Tissue "Hypoxia" and the Maintenance of Leukemia Stem Cells.

  2019cites this paper
• Imatinib-mesylate enhances the maintenance of chronic myeloid leukemia stem cell potential in the absence of glucose.

  2018cites this paper
• Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures

  2018cites this paper
• Sensitivity to imatinib of KCL22 chronic myeloid leukemia cell survival/growth and stem cell potential under glucose shortage

  2018influential citation
• Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells

  2018cites this paper
• Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.

  2017cites this paper
• The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction

  2017influential citation
• The hypoxia signalling pathway in haematological malignancies

  2017cites this paper
• Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.

  2017influential citation
• Antioxidant Systems, Thioredoxin and DJ-1: Novel Therapeutic Targets in Multiple Myeloma

  2017cites this paper
• Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence

  2017influential citation
• TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition

  2016cites this paper
• The Culture Repopulation Ability (CRA) Assay and Incubation in Low Oxygen to Test Antileukemic Drugs on Imatinib-Resistant CML Stem-Like Cells.

  2016cites this paper
• Hypoxia and Hypoxia-Inducible Factors in Leukemias

  2016cites this paper
• Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation

  2016cites this paper
• Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions

  2016cites this paper
• Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells

  2016cites this paper
• Persistence to anti-cancer treatments in the stationary to proliferating transition

  2016cites this paper
• Chronic Myeloid Leukaemia Stem Cells are sensitive to the pharmacological inhibition of Hypoxia Inducible Factor-1 α

  2015influential citation
• The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents

  2015cites this paper
• Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells

  2015cites this paper
• One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment

  2014cites this paper
• Stem Cells Increase in Numbers in Perinecrotic Areas in Human Renal Cancer

  2014cites this paper
• One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment

  2014cites this paper
• One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment

  2014cites this paper
• The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy

  2014cites this paper
• One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment

  2014cites this paper
• Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies.

  2014cites this paper
• Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells.

  2014cites this paper
• Anticancer efficiency of reovirus in normoxia and hypoxia.

  2013cites this paper
• Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets

  2013cites this paper
• The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells

  2013cites this paper
• The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression

  2013cites this paper
• Emerging Opportunities for Targeting the Tumor–Stroma Interactions for Increasing the Efficacy of Chemotherapy

  2013cites this paper
• Activity of the Hypoxia-Activated Prodrug, TH-302, in Preclinical Human Acute Myeloid Leukemia Models

  2013cites this paper
• AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia

  2013cites this paper
• CXCR4 Antagonists for the Treatment of CML

  2012cites this paper
• Multifaceted mechanisms for cell survival and drug targeting in chronic myelogenous leukemia.

  2012cites this paper
• Targeting RAD 51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL 1 leukemia

  2011cites this paper
• Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr‐Abl positive leukemic cells

  2011cites this paper
• Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition.

  2011cites this paper
• Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.

  2011cites this paper
• Valproic acid overcomes hypoxia-induced resistance to apoptosis

  2011cites this paper
• Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate

  2011cites this paper
• Hypoxia Selects Bortezomib-Resistant Stem Cells of Chronic Myeloid Leukemia

  2011cites this paper
• Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65--a novel Wnt/β-catenin signaling inhibitor.

  2011cites this paper
• Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia.

  2011cites this paper
• Very low oxygen concentration (0.1%) reveals two FDCP-Mix cell subpopulations that differ by their cell cycling, differentiation and p27KIP1 expression

  2011cites this paper
• Imatinib-resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprogramming

  2010cites this paper
• Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environment

  2010cites this paper
• Why doesn't imatinib cure chronic myeloid leukemia?

  2010cites this paper
• Survival or Death: The Redox Paradox

  2009cites this paper
• Environmental restrictions within tumor ecosystems select for a convergent, hypoxia-resistant phenotype of cancer stem cells

  2008cites this paper
• Severe Hypoxia Defines Heterogeneity and Selects Highly Immature Progenitors Within Clonal Erythroleukemia Cells

  2007cites this paper